Factors associated with hepatitis B mother-to-child transmission in a national prevention program
Clinical and Molecular Hepatology · 2025
DOI: 10.3350/cmh.2025.0214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Moran Ki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health & AI, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Infectious Disease Transmission, Vertical, Hepatitis B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Korea Disease Control and Prevention Agency, National Cancer Center, SK bioscience.
Abstract (Originalsprache)
Background/Aims: Hepatitis B virus (HBV) mother-to-child transmission (MTCT) remains a global health concern, with over 90% of perinatal infections leading to chronic HBV. To evaluate long-term trends in MTCT rates and associated factors within Korea’s national program.
Methods
Population-based cohort study using linked data from the Perinatal Hepatitis B Prevention Program (PHBPP) and National Health Insurance Service in Korea. The study included HBsAg-positive mother-infant pairs with post-vaccination serologic results from 2002 to 2021.
Results
Among the 154,478 mother-infant pairs, the overall MTCT rate after prophylaxis was 2.3%. Antiviral use lowered MTCT rates (0.9% vs. 2.4%) particularly in HBeAg-positivity (1.0% vs. 5.9%; adjusted odds ratio [aOR] 0.21; 95% confidence interval [CI] 0.14–0.32). Lower MTCT rates were observed for cesarean section vs. vaginal delivery (1.9% vs. 2.6%; aOR 0.78; 95% CI 0.73–0.84) and breastfeeding vs. formula feeding (1.8% vs. 2.8%; aOR 0.65; 95% CI 0.56–0.76). Annual MTCT rates decreased from 3.6% (2002–2005) to 1.3% (2018–2021). Antivirals reduced MTCT rates; initiation at 14–27 weeks (0.39%), or 28–32 weeks (0.44%) vs. ≥33 weeks (1.47%); postpartum continuation (0.55%) vs. antepartum discontinuation (1.44%); use ≥61 days (0.51%) vs. 1–60 days (1.67%). Lower MTCT risk was associated with maternal (old age, high income) and infant (female sex, preterm birth) factors.
Conclusions
This comprehensive analysis of the PHBPP in Korea demonstrates that the use of antivirals, breastfeeding, and cesarean section, combined with conventional immunoprophylaxis, has significantly reduced MTCT rates. These results are crucial for global HBV elimination and can help to guide HBV MTCT prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health & AI, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
- Division of Pediatric Infectious Diseases, Department of Pediatrics, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Förderung
- Korea Disease Control and Prevention Agency
- National Cancer Center
- SK bioscience
Zitieren
APA
Ki, M., Kim, B. W., Baik, D., & Kim, J. H. (2025). Factors associated with hepatitis B mother-to-child transmission in a national prevention program. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2025.0214
Vancouver
Ki M, Kim BW, Baik D, Kim JH. Factors associated with hepatitis B mother-to-child transmission in a national prevention program. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2025.0214
BibTeX
@article{Ki2025,
author = {Ki, Moran and Kim, Byung-Woo and Baik, Dahye and Kim, Jong-Hyun},
title = {Factors associated with hepatitis B mother-to-child transmission in a national prevention program},
journal = {Clinical and Molecular Hepatology},
year = {2025},
doi = {10.3350/cmh.2025.0214}
}
EUVIMED